Literature DB >> 25232513

Somatic complaints in frontotemporal dementia.

Maria Landqvist Waldö1, Alexander Frizell Santillo2, Lars Gustafson1, Elisabet Englund3, Ulla Passant1.   

Abstract

Frontotemporal dementia (FTD) is associated with a broad spectrum of clinical characteristics. The objective of this study was to analyze the prevalence of unexplained somatic complaints in neuropathologically verified FTD. We also examined whether the somatic presentations correlated with protein pathology or regional brain pathology and if the patients with these somatic features showed more depressive traits. Ninety-seven consecutively neuropathologically verified FTLD patients were selected. All 97 patients were part of a longitudinal study of FTD and all medical records were systematically reviewed. The somatic complaints focused on were headache, musculoskeletal, gastro/urogenital and abnormal pain response. Symptoms of somatic character (either somatic complaints and/or abnormal pain response) were found in 40.2%. These patients did not differ from the total group with regard to gender, age at onset or duration. Six patients showed exaggerated reactions to sensory stimuli, whereas three patients showed reduced response to pain. Depressive traits were present in 38% and did not correlate with somatic complaints. Suicidal behavior was present in 17 patients, in 10 of these suicidal behavior was concurrent with somatic complaints. No clear correlation between somatic complaints and brain protein pathology, regional pathology or asymmetric hemispherical atrophy was found. Our results show that many FTD patients suffer from unexplained somatic complaints before and/or during dementia where no clear correlation can be found with protein pathology or regional degeneration. Somatic complaints are not covered by current diagnostic criteria for FTD, but need to be considered in diagnostics and care. The need for prospective studies with neuropathological follow up must be stressed as these phenomena remain unexplained, misinterpreted, bizarre and, in many cases, excruciating.

Entities:  

Keywords:  Frontotemporal dementia; depressive mood; neuropathology; pain; sensory disturbances; somatic complaints; suicidal behavior

Year:  2014        PMID: 25232513      PMCID: PMC4162589     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  31 in total

1.  Initial complaints in frontotemporal lobar degeneration.

Authors:  Yolande A L Pijnenburg; Freek Gillissen; Cees Jonker; Philip Scheltens
Journal:  Dement Geriatr Cogn Disord       Date:  2004       Impact factor: 2.959

2.  Pain affect encoded in human anterior cingulate but not somatosensory cortex.

Authors:  P Rainville; G H Duncan; D D Price; B Carrier; M C Bushnell
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

3.  Neural networks in frontotemporal dementia--a meta-analysis.

Authors:  Matthias L Schroeter; Karolina Raczka; Jane Neumann; D Yves von Cramon
Journal:  Neurobiol Aging       Date:  2006-11-30       Impact factor: 4.673

4.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia.

Authors:  H J Rosen; M L Gorno-Tempini; W P Goldman; R J Perry; N Schuff; M Weiner; R Feiwell; J H Kramer; B L Miller
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

Review 5.  Making the diagnosis of frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  Arch Pathol Lab Med       Date:  2013-03       Impact factor: 5.534

Review 6.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

7.  Distinct behavioural profiles in frontotemporal dementia and semantic dementia.

Authors:  J S Snowden; D Bathgate; A Varma; A Blackshaw; Z C Gibbons; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

8.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

9.  The clinical profile of right temporal lobe atrophy.

Authors:  Dennis Chan; Valerie Anderson; Yolande Pijnenburg; Jennifer Whitwell; Jo Barnes; Rachael Scahill; John M Stevens; Frederik Barkhof; Philip Scheltens; Martin N Rossor; Nick C Fox
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

Review 10.  The amygdala between sensation and affect: a role in pain.

Authors:  Pierre Veinante; Ipek Yalcin; Michel Barrot
Journal:  J Mol Psychiatry       Date:  2013-06-05
View more
  4 in total

1.  Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population.

Authors:  Mfon E Umoh; Christina Fournier; Yingjie Li; Meraida Polak; Latoya Shaw; John E Landers; William Hu; Marla Gearing; Jonathan D Glass
Journal:  Neurology       Date:  2016-08-03       Impact factor: 9.910

Review 2.  Premorbid de novo artistic creativity in frontotemporal dementia (FTD) syndromes.

Authors:  Felix Geser; Tibor C G Mitrovics; Johannes Haybaeck; Deniz Yilmazer-Hanke
Journal:  J Neural Transm (Vienna)       Date:  2021-10-07       Impact factor: 3.575

3.  Pain and temperature processing in dementia: a clinical and neuroanatomical analysis.

Authors:  Phillip D Fletcher; Laura E Downey; Hannah L Golden; Camilla N Clark; Catherine F Slattery; Ross W Paterson; Jonathan D Rohrer; Jonathan M Schott; Martin N Rossor; Jason D Warren
Journal:  Brain       Date:  2015-10-12       Impact factor: 13.501

4.  Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma?

Authors:  Maria Landqvist Waldö; Lars Gustafson; Ulla Passant; Elisabet Englund
Journal:  Int Psychogeriatr       Date:  2014-12-09       Impact factor: 3.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.